Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

A longitudinal study of serum insulin and glucose levels in relation to colorectal cancer risk among postmenopausal women.

Kabat GC, Kim MY, Strickler HD, Shikany JM, Lane D, Luo J, Ning Y, Gunter MJ, Rohan TE.

Br J Cancer. 2012 Jan 3;106(1):227-32. doi: 10.1038/bjc.2011.512. Epub 2011 Nov 29.

2.

Repeated measurements of serum carotenoid, retinol and tocopherol levels in relation to colorectal cancer risk in the Women's Health Initiative.

Kabat GC, Kim MY, Sarto GE, Shikany JM, Rohan TE.

Eur J Clin Nutr. 2012 May;66(5):549-54. doi: 10.1038/ejcn.2011.207. Epub 2011 Dec 14.

PMID:
22166899
3.

Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women.

Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Rohan TE, Manson JE, Li J, Ho GY, Xue X, Anderson GL, Kaplan RC, Harris TG, Howard BV, Wylie-Rosett J, Burk RD, Strickler HD.

J Natl Cancer Inst. 2009 Jan 7;101(1):48-60. doi: 10.1093/jnci/djn415. Epub 2008 Dec 30.

4.

Repeated measures of serum glucose and insulin in relation to postmenopausal breast cancer.

Kabat GC, Kim M, Caan BJ, Chlebowski RT, Gunter MJ, Ho GY, Rodriguez BL, Shikany JM, Strickler HD, Vitolins MZ, Rohan TE.

Int J Cancer. 2009 Dec 1;125(11):2704-10. doi: 10.1002/ijc.24609.

5.

A longitudinal study of the metabolic syndrome and risk of colorectal cancer in postmenopausal women.

Kabat GC, Kim MY, Peters U, Stefanick M, Hou L, Wactawski-Wende J, Messina C, Shikany JM, Rohan TE.

Eur J Cancer Prev. 2012 Jul;21(4):326-32. doi: 10.1097/CEJ.0b013e32834dbc81.

PMID:
22044849
6.

Increased blood glucose and insulin, body size, and incident colorectal cancer.

Schoen RE, Tangen CM, Kuller LH, Burke GL, Cushman M, Tracy RP, Dobs A, Savage PJ.

J Natl Cancer Inst. 1999 Jul 7;91(13):1147-54.

PMID:
10393723
7.

Fasting glucose is a risk factor for breast cancer: a prospective study.

Muti P, Quattrin T, Grant BJ, Krogh V, Micheli A, Schünemann HJ, Ram M, Freudenheim JL, Sieri S, Trevisan M, Berrino F.

Cancer Epidemiol Biomarkers Prev. 2002 Nov;11(11):1361-8.

8.

A longitudinal study of the metabolic syndrome and risk of postmenopausal breast cancer.

Kabat GC, Kim M, Chlebowski RT, Khandekar J, Ko MG, McTiernan A, Neuhouser ML, Parker DR, Shikany JM, Stefanick ML, Thomson CA, Rohan TE.

Cancer Epidemiol Biomarkers Prev. 2009 Jul;18(7):2046-53. doi: 10.1158/1055-9965.EPI-09-0235. Epub 2009 Jun 30.

9.

Prospective study of leukocyte count as a predictor of incident breast, colorectal, endometrial, and lung cancer and mortality in postmenopausal women.

Margolis KL, Rodabough RJ, Thomson CA, Lopez AM, McTiernan A; Women's Health Initiative Research Group.

Arch Intern Med. 2007 Sep 24;167(17):1837-44.

PMID:
17893304
10.

Insulin, glucose, insulin resistance, and incident colorectal cancer in male smokers.

Limburg PJ, Stolzenberg-Solomon RZ, Vierkant RA, Roberts K, Sellers TA, Taylor PR, Virtamo J, Cerhan JR, Albanes D.

Clin Gastroenterol Hepatol. 2006 Dec;4(12):1514-21.

11.

Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women.

Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Rohan TE, Manson JE, Howard BV, Wylie-Rosett J, Anderson GL, Ho GY, Kaplan RC, Li J, Xue X, Harris TG, Burk RD, Strickler HD.

Cancer Res. 2008 Jan 1;68(1):329-37. doi: 10.1158/0008-5472.CAN-07-2946.

12.

C-reactive protein levels are not associated with increased risk for colorectal cancer in women.

Zhang SM, Buring JE, Lee IM, Cook NR, Ridker PM.

Ann Intern Med. 2005 Mar 15;142(6):425-32.

PMID:
15767620
13.

Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.

Krajcik RA, Borofsky ND, Massardo S, Orentreich N.

Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1566-73.

14.

Nonsteroidal anti-inflammatory drugs and subsite-specific colorectal cancer incidence in the Iowa women's health study.

Mahipal A, Anderson KE, Limburg PJ, Folsom AR.

Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1785-90.

15.

Carbohydrate intake, glycemic index, glycemic load, and risk of postmenopausal breast cancer in a prospective study of French women.

Lajous M, Boutron-Ruault MC, Fabre A, Clavel-Chapelon F, Romieu I.

Am J Clin Nutr. 2008 May;87(5):1384-91.

16.

Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women.

Kaaks R, Toniolo P, Akhmedkhanov A, Lukanova A, Biessy C, Dechaud H, Rinaldi S, Zeleniuch-Jacquotte A, Shore RE, Riboli E.

J Natl Cancer Inst. 2000 Oct 4;92(19):1592-600.

PMID:
11018095
17.

Colorectal cancer incidence and postmenopausal hormone use by type, recency, and duration in cancer prevention study II.

Hildebrand JS, Jacobs EJ, Campbell PT, McCullough ML, Teras LR, Thun MJ, Gapstur SM.

Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):2835-41. doi: 10.1158/1055-9965.EPI-09-0596. Epub 2009 Oct 20.

19.

Cigarette smoking and colorectal cancer: long-term, subsite-specific risks in a cohort study of postmenopausal women.

Limburg PJ, Vierkant RA, Cerhan JR, Yang P, Lazovich D, Potter JD, Sellers TA.

Clin Gastroenterol Hepatol. 2003 May;1(3):202-10.

PMID:
15017492
20.

A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women.

Giovannucci E, Pollak MN, Platz EA, Willett WC, Stampfer MJ, Majeed N, Colditz GA, Speizer FE, Hankinson SE.

Cancer Epidemiol Biomarkers Prev. 2000 Apr;9(4):345-9.

Supplemental Content

Support Center